Skip to main content

Table 2 Treatment-related toxicity (n = 31)

From: Evaluation of safety and efficacy of gefitinib ('iressa', zd1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer: experience from a compassionate-use programme

Adverse events

Grade

Total

 

1

2

3

  
 

n

%

n

%

n

%

n

%

Acneform rash

17

54.8

3

9.7

1

3.2

21

67.7

Diarrhoea

10

32.3

1

3.2

-

-

11

35.5

Nausea

1

3.2

1

3.2

-

-

2

6.5

Vomiting

-

-

1

3.2

-

-

1

3.2

Stomatitis

4

12.9

-

-

-

-

4

12.9

Increased ALT

1

3.2

-

-

-

-

1

3.2

Increased AST

1

3.2

-

-

-

-

1

3.2

  1. ALT, alkaline aminotransferase; AST, aspartate aminotransferase
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us